ATE185275T1 - Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren - Google Patents
Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulierenInfo
- Publication number
- ATE185275T1 ATE185275T1 AT92919588T AT92919588T ATE185275T1 AT E185275 T1 ATE185275 T1 AT E185275T1 AT 92919588 T AT92919588 T AT 92919588T AT 92919588 T AT92919588 T AT 92919588T AT E185275 T1 ATE185275 T1 AT E185275T1
- Authority
- AT
- Austria
- Prior art keywords
- wide range
- stimulate
- determinants
- against hiv
- responses against
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 210000004698 lymphocyte Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 208000007521 HIV Seropositivity Diseases 0.000 abstract 1
- 208000037357 HIV infectious disease Diseases 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 210000002443 helper t lymphocyte Anatomy 0.000 abstract 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US75199891A | 1991-08-29 | 1991-08-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE185275T1 true ATE185275T1 (de) | 1999-10-15 |
Family
ID=25024412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT92919588T ATE185275T1 (de) | 1991-08-29 | 1992-08-31 | Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0601108B1 (de) |
JP (1) | JPH07501516A (de) |
AT (1) | ATE185275T1 (de) |
AU (1) | AU665023B2 (de) |
CA (1) | CA2114849C (de) |
DE (1) | DE69230106T2 (de) |
DK (1) | DK0601108T3 (de) |
ES (1) | ES2257733T3 (de) |
WO (1) | WO1993004697A1 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6294322B1 (en) | 1988-01-26 | 2001-09-25 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptides that elicit helper T-lymphocyte cytotoxic T-lymphocyte and neutralizing antibody responses against HIV-1 |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
US5128319A (en) | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
WO1995003067A1 (en) * | 1993-07-21 | 1995-02-02 | Khavinson Vladimir Khatskelevi | Pharmaceutical with immunomodulating activity |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
US5972339A (en) * | 1997-11-13 | 1999-10-26 | The General Hospital Corporation | Method of eliciting anti-HIV-1 helper T cell responses |
IL150961A0 (en) | 2000-02-04 | 2003-02-12 | Univ Duke | Human immunodeficiency virus vaccine |
CN110349627B (zh) * | 2019-06-27 | 2021-08-27 | 杭州纽安津生物科技有限公司 | 多肽疫苗序列的设计方法及其自动化设计产品 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5030449A (en) * | 1988-07-21 | 1991-07-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Synthetic vaccine against AIDS virus |
WO1988005051A1 (en) * | 1986-12-30 | 1988-07-14 | United States Of America, Represented By The Unite | Synthetic peptides which induce cellular immunity of the aids virus and aids viral proteins |
ATE151638T1 (de) * | 1987-02-20 | 1997-05-15 | Genentech Inc | Verfahren und zubereitungen für die verwendung von hiv-env-polypeptiden und antikörpern |
AU2914889A (en) * | 1987-08-28 | 1989-04-17 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
EP0317804B1 (de) * | 1987-11-24 | 1995-10-04 | Abbott Laboratories | HIV-Peptide und Methoden für den Nachweis von HIV |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
US4943628A (en) * | 1988-06-13 | 1990-07-24 | Ortho Pharmaceutical Corporation | HIV peptide-inducted T cell stimulation |
CA2003383A1 (en) * | 1988-11-23 | 1990-05-23 | Sushil G. Devare | Synthetic dna derived recombinant hiv antigens |
CA2078545A1 (en) * | 1990-04-03 | 1991-10-04 | Timothy J. Gregory | Hiv envelope polypeptides |
ES2194836T3 (es) * | 1990-09-27 | 2003-12-01 | Tripep Ab | Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana. |
-
1992
- 1992-08-31 DK DK92919588T patent/DK0601108T3/da active
- 1992-08-31 EP EP92919588A patent/EP0601108B1/de not_active Expired - Lifetime
- 1992-08-31 JP JP5505385A patent/JPH07501516A/ja active Pending
- 1992-08-31 CA CA002114849A patent/CA2114849C/en not_active Expired - Lifetime
- 1992-08-31 WO PCT/US1992/007422 patent/WO1993004697A1/en active IP Right Grant
- 1992-08-31 AU AU25693/92A patent/AU665023B2/en not_active Ceased
- 1992-08-31 AT AT92919588T patent/ATE185275T1/de active
- 1992-08-31 ES ES92919588T patent/ES2257733T3/es not_active Expired - Lifetime
- 1992-08-31 DE DE69230106T patent/DE69230106T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2114849A1 (en) | 1993-03-18 |
EP0601108A4 (en) | 1997-03-19 |
AU2569392A (en) | 1993-04-05 |
DE69230106D1 (de) | 1999-11-11 |
AU665023B2 (en) | 1995-12-14 |
EP0601108A1 (de) | 1994-06-15 |
CA2114849C (en) | 2007-04-24 |
WO1993004697A1 (en) | 1993-03-18 |
DK0601108T3 (da) | 2000-04-17 |
ES2257733T3 (es) | 2006-08-01 |
DE69230106T2 (de) | 2000-03-30 |
EP0601108B1 (de) | 1999-10-06 |
JPH07501516A (ja) | 1995-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2255093A (en) | Hiv-1 core protein fragments | |
DE69233772D1 (de) | T-zell epitopen von den wichtigsten allergene von dermatophagoides (hausmilbe) | |
ATE104348T1 (de) | O-glycosyliertes ifn-alpha. | |
ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
DE3886506D1 (de) | Avirulente mikroben und deren verwendungen. | |
EP0909814A3 (de) | Verwendung von Proteinkinasen zur Diagnose und Behandlung der Alzheimer'schen Krankheit | |
DK614987A (da) | Syntetiske htlv-iii peptider, praeparater og anvendelser deraf | |
ATE144143T1 (de) | Künstlicher impfstoff gegen aids-virus | |
ATE149202T1 (de) | Gentechnologisch veränderte bakteriophagen und sie enthaltende impfstoffe | |
FR2697022B1 (fr) | Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination. | |
NO912825D0 (no) | Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper. | |
ATE210721T1 (de) | Verwendung eines mbp peptides zur herstellung eines medikamentes für die behandlung von multipler sclerose | |
ATE185275T1 (de) | Peptid-antigene bestehend aus multi- determinanten, die die t-helfer lymphozyten- antwort gegen hiv in einem weiten bereich von betroffenen menschen stimulieren | |
NO941370L (no) | Rekombitope peptider | |
ES2080047T3 (es) | Peptidos hiv y metodos para la deteccion de hiv. | |
DE3879968D1 (de) | Malaria-impfstoff aus copolymerem protein. | |
DE69007571D1 (de) | Peptidfragmente von HIV. | |
ATE105938T1 (de) | Monoklonale antikörper gegen spezifische antigene regionen des humanen immundefizienzvirus und methoden zur verwendung. | |
ES2176363T3 (es) | Peptidos de la proteina gag del vih, su preparacion y su uso. | |
DE68926245D1 (de) | Nachweis der basismembrankomponenten, diagnose von krebs und sonstigen krankheiten | |
SE8803062D0 (sv) | Sequential polypeptides endowed with immunological activity | |
DE69433057D1 (de) | Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus | |
DE69122850D1 (de) | Konformationsepitope des humanen Immundefizienzvirus-Hüllprotein-gp120 | |
OA08974A (en) | New immunologically active synthetic peptides useful for preparing an antimalarial vaccine | |
MX9200711A (es) | Un antigeno de fases sanguineas de plasmodium falciparum su preparacion y utilizacion. |